Invention Grant
- Patent Title: Pyrimidine compounds as mTOR and PI3K inhibitors
- Patent Title (中): 嘧啶化合物作为mTOR和PI3K抑制剂
-
Application No.: US14192301Application Date: 2014-02-27
-
Publication No.: US09315491B2Publication Date: 2016-04-19
- Inventor: Mann-Yan Kuo , Ying-Shuan Lee , Paonien Chen , Li Jung Chen , Yann Yu Lu , Yi-Ting Huang , Hung-Yi Hsu , Ping-Kuei Tsai
- Applicant: DEVELOPMENT CENTER FOR BIOTECHNOLOGY , DCB-USA LLC
- Applicant Address: TW New Taipei US DE New Castle
- Assignee: DEVELOPMENT CENTER FOR BIOTECHNOLOGY,DCB-USA LLC
- Current Assignee: DEVELOPMENT CENTER FOR BIOTECHNOLOGY,DCB-USA LLC
- Current Assignee Address: TW New Taipei US DE New Castle
- Agency: Sughrue Mion, PLLC
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D239/47 ; A61K31/506 ; C07D401/04 ; C07D401/14 ; C07D413/04 ; A61K31/541 ; A61K45/06 ; C07D413/14 ; C07D417/14 ; C07D403/12 ; C07D409/12 ; C07D413/12
Abstract:
The present invention relates to pyrimidine compounds of formula (I): which are useful in treating mTOR kinase- or PI3K kinase-related diseases.
Public/Granted literature
- US20140178360A1 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS Public/Granted day:2014-06-26
Information query
IPC分类:
